首页> 外文期刊>Naunyn-Schmiedeberg's Archives of Pharmacology >Repeated administration of the novel antipsychotic olanzapine does not modulate NMDA-sensitive glutamate and 5HT2 serotonin receptors in rats.
【24h】

Repeated administration of the novel antipsychotic olanzapine does not modulate NMDA-sensitive glutamate and 5HT2 serotonin receptors in rats.

机译:反复服用新型抗精神病药物奥氮平不会调节大鼠的NMDA敏感性谷氨酸和5HT2血清素受体。

获取原文
获取原文并翻译 | 示例
           

摘要

Antipsychotic drugs reportedly show a common property in facilitating glutamatergic transmission in rat cerebral cortex. Since the binding of the radiolabelled channel blocker [3H]-MK801 is generally considered an affordable index of N-methyl-d-aspartate (NMDA)-sensitive glutamate receptor activation, we examined the effects of clinically effective treatment (3 weeks, daily administration) of the atypical antipsychotic drug olanzapine (32 micromol/kg/5 ml) on the specific binding of [3H]-MK801 specific binding and on the strychnine-insensitive glycine sites (glycine B) in synaptic plasma membranes (SPM) prepared from the medial prefrontal cortex (mPFC) of rats sacrificed after different (24, 60, 120 h) washout periods. We studied also the effects of repeated olanzapine administration on [3H]-ketanserin binding to 5HT2A receptors to verify whether, consistent with previously reported paradoxical effects of repeated administration of 5HT2A antagonists, this drug decreases 5HT2A receptor density without changing the apparent affinity. Neither single nor repeated olanzapine administration changed the kinetic characteristics of [3H]-MK801 or [3H]-glycine specific binding. When rats were sacrificed 120 h after the last olanzapine administration, both single or repeated treatment had failed to change the kinetic characteristics of [3H]-ketanserin binding, while the apparent affinity of 5HT2A receptors was increased in animals sacrificed at shorter (60 h) washout periods. Owing to the long half-life of olanzapine (24 h), and since the drug concentrations in mPFC of rats sacrificed 60 h after a single olanzapine administration (about 50 nM) are high enough to induce changes in 5HT2A receptor affinity, it is concluded that this modification, probably unrelated to the therapeutic efficacy, could be due to some drug still present in the brain at the time of the sacrifice.
机译:据报道,抗精神病药在促进大鼠大脑皮质中的谷氨酸能传递方面显示出共同的特性。由于放射性标记的通道阻滞剂[3H] -MK801的结合通常被认为是N-甲基-d-天冬氨酸(NMDA)敏感的谷氨酸受体激活的负担得起的指数,因此我们检查了临床有效治疗的效果(3周,每日给药)非典型抗精神病药物奥氮平(32 micromol / kg / 5 ml)对[3H] -MK801特异性结合的特异性结合以及对突触质膜(SPM)中对苯丙氨酸不敏感的甘氨酸位点(甘氨酸B)的抑制作用在不同(24、60、120 h)冲洗期后处死大鼠的前额内侧皮层(mPFC)。我们还研究了奥氮平重复给药对[3H]-酮色林与5HT2A受体结合的影响,以验证与先前报道的重复给药5HT2A拮抗剂的悖论作用一致,该药物是否在不改变表观亲和力的情况下降低了5HT2A受体的密度。单次或反复服用奥氮平均不会改变[3H] -MK801或[3H]-甘氨酸特异性结合的动力学特性。在最后一次奥氮平给药后120小时处死大鼠时,单次或重复治疗均未改变[3H]-酮色林结合的动力学特征,而在较短时间(60 h)处死的动物中5HT2A受体的表观亲和力增加了。冲洗期。由于奥氮平具有较长的半衰期(24小时),并且由于单次给药奥氮平(约50 nM)后60 h处死的大鼠mPFC中的药物浓度足以诱导5HT2A受体亲和力发生变化,因此得出结论这种修饰可能与治疗功效无关,可能是由于牺牲时大脑中仍存在某种药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号